IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
18 hedge funds and large institutions have $3.72M invested in Interpace Biosciences, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
+5
Holders Change %
+38.46%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
4
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.35M |
2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$558K |
3 |
VF
Virtu Financial
New York
|
+$133K |
4 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$93K |
5 |
WS
Wedbush Securities
Los Angeles,
California
|
+$49.8K |
Top Sellers
1 |
TSS
Two Sigma Securities
New York
|
-$72K |